Imagion (ASX:IBX) share price zips 38% higher. Here's why

The Imagion Biosystems Ltd share price is up 38% today following an update on its MagSense HER2 breast cancer study. Here's what the company announced.

| More on:
rising medical asx share price represented by excited doctors dancing in ward

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

The Imagion Biosystems Ltd (ASX: IBX) share price is rebounding strongly after weeks of severe falls. This comes after the company provided an update on its MagSense HER2 breast cancer study.

During mid-afternoon trade, the biotechnology and nanotechnology company's shares are 38.3% higher to 13 cents.

What was announced?

According to its release, Imagion advised that it has enrolled its first patient in the MagSense HER2 breast cancer Phase I first-in-human study.

The program aims to investigate the use of a MagSense imaging agent to increase the accuracy in detecting a patient's HER2 breast cancer. More specifically, the nanotechnology looks to see if the tumour has spread to the patient's lymph nodes.

Traditionally, the current standard of care involves a biopsy or surgical removal of the lymph nodes to confirm metastases. Approximately half of HER2 breast cancer patients have no nodal disease. Furthermore, this allows MagSense to provide non-invasive procedures in detecting cancer.

Each patient in the study receives an injection of the MagSense nanoparticle imaging agent and undergoes imaging by MRI. While this occurs, a sample of the lymph node is also assessed using the MagSense magnetic relaxometry technology.

Imagion is expecting to enrol a total of 15 participants in the phase 1 study. The aim of the program is to determine the safety and tolerability of the MagSense imaging agent. Furthermore, the company is also exploring the effectiveness of the nanoparticles for in vivo detection.

Imagion Biosystems executive chair, Bob Proulx commented:

We are very pleased to report our first patient has been enrolled in this ground-breaking study. Though recruiting newly diagnosed cancer patients into a research study can be challenging, we and our investigators remain confident we will reach our recruitment target. We are committed to explore all avenues to achieve our goal of completing this important study.

Imagion share price summary

Over the past 12 months, Imagion shares have gained more than 360%, but have fallen 10% on year-to-date performance. The company's share price reached an all-time high of 22.5 cents earlier this year.

Based on valuation metrics, Imagion commands a market capitalisation of roughly $135 million, with over $1 billion shares outstanding.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing end to a disappointing week for investors this Friday.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Betr, Centuria Capital, GR Engineering, and Mach7 shares are pushing higher

These shares are having a good finish to the week. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX gave up an afternoon lead to close lower today.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Clarity Pharmaceuticals, Kelsian, Life360, and Syrah shares are rising today

These shares are pushing higher on Thursday. But why?

Read more »

Man smiling on top of rocks with mountains in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were in a nervous mood today.

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Why Beach Energy, Boss Energy, Cochlear, and Light & Wonder shares are pushing higher

These shares are having a good time on hump day. But why?

Read more »

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing Tuesday session for ASX investors today.

Read more »

A man looking at his laptop and thinking.
Share Gainers

Thinking of selling your CBA shares? This expert says you should hold on

CBA shares are up by about 80% since November 2023.

Read more »